• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶:子痫前期-子痫的一种生化标志物。

Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia.

作者信息

Jaiswar S P, Gupta Amrit, Sachan Rekha, Natu S N, Shaili Mohan

机构信息

Department of Obstetrics and Gynecology, Queen Mary Hospital, CSMMU, Lucknow, UP India.

出版信息

J Obstet Gynaecol India. 2011 Dec;61(6):645-8. doi: 10.1007/s13224-011-0093-9. Epub 2012 Jan 4.

DOI:10.1007/s13224-011-0093-9
PMID:23204682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3307931/
Abstract

OBJECTIVES

To correlate the severity of the disease, maternal and perinatal outcome with Lactic Dehydrogenase (LDH) levels in serum in patients of preeclampsia and eclampsia.

METHODS

A prospective comparative study was conducted in the department of Obstetrics and Gynecology in the collaboration with department of Pathology, CSM Medical University, Lucknow. Out of 146 women studied, 39 were normal pregnant women, 35 were of mild preeclampsia, 36 of severe preeclampsia and 36 of eclampsia. The statistical analysis was done by Chi-square test (for proportional data) analysis of variance and sample "t" test (for parametric data).

RESULTS

LDH levels were significantly elevated in women with preeclampsia and eclampsia (<0.001). Higher LDH levels had significant correlation with high blood pressure (P < 0.10) as well as poor maternal and perinatal outcome.

CONCLUSION

High serum LDH levels correlate well with the severity of the disease and poor outcomes in patients of preeclampsia and eclampsia.

摘要

目的

探讨子痫前期和子痫患者血清乳酸脱氢酶(LDH)水平与疾病严重程度、孕产妇及围产儿结局之间的相关性。

方法

在勒克瑙CSM医学院妇产科与病理科合作开展了一项前瞻性对照研究。在146名研究对象中,39名是正常孕妇,35名是轻度子痫前期患者,36名是重度子痫前期患者,36名是子痫患者。采用卡方检验(用于比例数据)、方差分析和样本t检验(用于参数数据)进行统计学分析。

结果

子痫前期和子痫患者的LDH水平显著升高(<0.001)。较高的LDH水平与高血压(P < 0.10)以及不良的孕产妇和围产儿结局显著相关。

结论

血清LDH水平升高与子痫前期和子痫患者的疾病严重程度及不良结局密切相关。

相似文献

1
Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia.乳酸脱氢酶:子痫前期-子痫的一种生化标志物。
J Obstet Gynaecol India. 2011 Dec;61(6):645-8. doi: 10.1007/s13224-011-0093-9. Epub 2012 Jan 4.
2
Evaluation of total LDH and its isoenzymes as markers in preeclampsia.评估总乳酸脱氢酶及其同工酶作为子痫前期标志物的作用。
J Med Biochem. 2020 Sep 2;39(3):392-398. doi: 10.2478/jomb-2019-0045.
3
LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia.乳酸脱氢酶(LDH):预测先兆子痫和子痫不良结局的生化标志物。
J Obstet Gynaecol India. 2016 Feb;66(1):23-9. doi: 10.1007/s13224-014-0645-x. Epub 2014 Dec 2.
4
A Study on Serum Lactate Dehydrogenase and Uric Acid in Preeclampsia and Eclampsia: Can they Predict Adverse Fetomaternal Outcome?子痫前期和子痫患者血清乳酸脱氢酶及尿酸的研究:它们能否预测不良母婴结局?
Int J Appl Basic Med Res. 2023 Apr-Jun;13(2):95-100. doi: 10.4103/ijabmr.ijabmr_626_22. Epub 2023 Jul 17.
5
Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia.
Med Sci Monit. 2005 Aug;11(8):CR393-7. Epub 2005 Jul 25.
6
Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.血清可溶性内皮糖蛋白水平在子痫前期和子痫中的诊断及预后意义
Adv Biomed Res. 2016 Jul 29;5:119. doi: 10.4103/2277-9175.186993. eCollection 2016.
7
The unfavorable slope from mild preeclampsia through severe preeclampsia, to eclampsia.从轻度子痫前期经重度子痫前期到子痫的不良发展趋势。
Pregnancy Hypertens. 2013 Apr;3(2):146-50. doi: 10.1016/j.preghy.2013.01.007. Epub 2013 Jan 19.
8
Perinatal outcome in singleton pregnancies complicated with preeclampsia and eclampsia in Ecuador.厄瓜多尔单胎妊娠合并子痫前期和子痫的围产期结局
J Obstet Gynaecol. 2016 Jul;36(5):581-4. doi: 10.3109/01443615.2015.1107532. Epub 2016 Jan 20.
9
An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.血清维生素D、可溶性内皮糖蛋白(sEng)、可溶性fms样酪氨酸激酶1(sFlt1)和血管内皮生长因子(VEGF)等血管生成相关因子在晚发型子痫前期诊断及严重程度中的作用分析
J Matern Fetal Neonatal Med. 2017 Jul;30(13):1602-1607. doi: 10.1080/14767058.2016.1219986. Epub 2016 Sep 23.
10
Role of Lactate Dehydrogenase in the Prediction of Severity in Pre- Eclampsia.乳酸脱氢酶在子痫前期严重程度预测中的作用
Curr Hypertens Rev. 2020;16(3):223-228. doi: 10.2174/1573402116666200720001032.

引用本文的文献

1
Antepartum Serum Lactate Dehydrogenase and Adverse Obstetric Outcomes in Preeclampsia: A Systematic Review of Prognostic Evidence From Low- and Middle-Income Countries.子痫前期产前血清乳酸脱氢酶与不良产科结局:低收入和中等收入国家预后证据的系统评价
Cureus. 2025 Jun 21;17(6):e86496. doi: 10.7759/cureus.86496. eCollection 2025 Jun.
2
Lactate dehydrogenase (LDH) as an indicator of pre-eclampsia.乳酸脱氢酶(LDH)作为子痫前期的一个指标。
Bioinformation. 2025 Feb 28;21(2):116-120. doi: 10.6026/973206300210116. eCollection 2025.
3
Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes.子痫前期患者血清乳酸脱氢酶水平及其与疾病严重程度、孕产妇和围产儿结局的相关性。
BMC Womens Health. 2025 Mar 10;25(1):108. doi: 10.1186/s12905-025-03622-5.
4
Diagnostic performance of lactate dehydrogenase as a potential biomarker in predicting preeclampsia and associated factors.乳酸脱氢酶作为预测子痫前期及相关因素潜在生物标志物的诊断性能
Front Med (Lausanne). 2024 May 10;11:1240848. doi: 10.3389/fmed.2024.1240848. eCollection 2024.
5
A Comprehensive Review on Serum Lactate Dehydrogenase (LDH) and Uric Acid in Preeclampsia: Implications for Maternal Health and Disease Severity.子痫前期血清乳酸脱氢酶(LDH)和尿酸的综合综述:对孕产妇健康和疾病严重程度的影响
Cureus. 2024 Mar 25;16(3):e56928. doi: 10.7759/cureus.56928. eCollection 2024 Mar.
6
The Role of Cardiac Biomarkers in the Diagnosis of Hypertensive Emergency.心脏生物标志物在高血压急症诊断中的作用
Diagnostics (Basel). 2023 Apr 30;13(9):1605. doi: 10.3390/diagnostics13091605.
7
Serum LDH Levels in Normotensive and Preeclamptic-Eclamptic Pregnant Women and Its Correlation With Fetomaternal Outcome.正常血压及子痫前期-子痫孕妇的血清乳酸脱氢酶水平及其与母婴结局的相关性
Cureus. 2023 Apr 6;15(4):e37220. doi: 10.7759/cureus.37220. eCollection 2023 Apr.
8
Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data.通过对常规收集的电子病历数据中的妊娠轨迹进行建模来改善子痫前期风险预测。
NPJ Digit Med. 2022 Jun 6;5(1):68. doi: 10.1038/s41746-022-00612-x.
9
Preclinical Trial of Traditional Plant Remedies for the Treatment of Complications of Gestational Malaria.传统植物疗法治疗妊娠期疟疾并发症的临床前试验
Medicines (Basel). 2021 Dec 17;8(12):79. doi: 10.3390/medicines8120079.
10
How to evaluate and treat the spectrum of TMA syndromes in pregnancy.如何评估和治疗妊娠相关性 TMA 综合征谱。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):545-551. doi: 10.1182/hematology.2021000290.

本文引用的文献

1
Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.影响重度子痫前期、子痫及溶血、肝酶升高和血小板减少综合征发病率及死亡率的因素。
Saudi Med J. 2006 Jul;27(7):1015-8.
2
Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia.
Med Sci Monit. 2005 Aug;11(8):CR393-7. Epub 2005 Jul 25.
3
Expectant management of early onset, severe pre-eclampsia: perinatal outcome.早发型重度子痫前期的期待治疗:围产期结局
BJOG. 2000 Oct;107(10):1258-64. doi: 10.1111/j.1471-0528.2000.tb11617.x.
4
Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity.重度子痫前期的早期风险评估:用于预测后续严重孕产妇发病可能性的入院症状和实验室检查组合
Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1407-14. doi: 10.1016/s0002-9378(99)70026-8.
5
Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death.
Am J Perinatol. 1995 Sep;12(5):310-3. doi: 10.1055/s-2007-994482.
6
Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants.子痫前期孕妇中乳酸脱氢酶浓度升高:小于胎龄儿出生的一个预测指标。
Gynecol Obstet Invest. 1995;39(4):234-8. doi: 10.1159/000292417.